Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
Abstract Background The renin‐angiotensin‐aldosterone system (RAAS), when chronically activated, is harmful and RAAS‐suppressive drugs are beneficial in the treatment of congestive heart failure (CHF). Mineralocorticoid receptor antagonists are widely used in the treatment of CHF in people. Hypothes...
Main Authors: | Melissa Coffman, Emilie Guillot, Thomas Blondel, Catherine Garelli‐Paar, Shuo Feng, Susanne Heartsill, Clarke E. Atkins |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.16155 |
Similar Items
-
Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
by: Darcy Adin, et al.
Published: (2021-05-01) -
Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease
by: Alberto Galizzi, et al.
Published: (2021-01-01) -
The effect of renal diet in association with enalapril or benazepril on proteinuria in dogs with proteinuric chronic kidney disease
by: A. Zatelli, et al.
Published: (2016-07-01) -
Interactions Between Aldosterone, Spironolactone and the Cardiotonic Steroids
by: Shidyak, Amjad
Published: (2008) -
Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo‐controlled clinical trial
by: Jonathan N. King, et al.
Published: (2019-11-01)